| Autor: |
Saxena, Nisha, Srivastava, Noopur, Shukla, Poonam, Tripathi, Govind Kumar |
| Předmět: |
|
| Zdroj: |
Journal of Drug Delivery & Therapeutics; 2019 Supplement, Vol. 9, p802-819, 18p |
| Abstrakt: |
Since decades Tuberculosis (TB) has been a foremost cause of mortality and morbidity with more than one-third of the world population infected with latent TB. Recent fight with an age old disease continuously smack with a dawdling approach toward its treatment. In spite of extensive researches in this field for combating the disease we are lacking behind in race with its causing agent Microbacterium Tuberculosis. Multidrug (MDR) and extensively drug resistant (XDR) Mycobacterium tuberculosis creates the worldwide open threat to human welfare. Thus there is a need of swift researches for its combat. Here in this review we are giving a brief description towards various chemical agents which have been used for its therapy and new families arrived as a potential drug candidate till date. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
